2023-508371-36-00CompletedPhase 1
A Study in Healthy Adult Male Participants to Evaluate the Metabolism of [14C]PF-06821497
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Pfizer Inc.
- Enrollment
- 6
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Sex
- Male
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Clinical Medical Lead
Scientific
Pfizer Inc.
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
A study in healthy men to test how well different doses of BI 3776528 are tolerated2024-515222-92-00Boehringer Ingelheim International GmbH118
Completed
Phase 1
A study in healthy men to test how well different doses of BI 3731579 are tolerated2023-510318-25-00Boehringer Ingelheim International GmbH64
Recruiting
Phase 1
A study in healthy men to find out how different doses of BI 3009947 are tolerated and how different formulations or food influence how BI 3009947 is taken up into the blood2025-521095-66-00Boehringer Ingelheim International GmbH68
Completed
Phase 4
A study in two groups of healthy male adult participants to assess how much test medicine (SAR441566) is taken up, degraded and removed by the body and to assess the extent to which SAR441566 becomes available to the body when given by mouth2023-508030-33-00Sanofi-Aventis Recherche & Developpement13
Completed
Phase 1
A study in healthy men to test how different doses of BI 3000202 are tolerated and how food influences the amount of BI 3000202 in the blood2022-502424-43-00Boehringer Ingelheim International GmbH68